Cargando…

Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria

By May 30, 2022, there were 526,182,662 confirmed COVID- 19 cases and 6,286,057 deaths globally; of which Nigeria had recorded 256,028 confirmed cases and 3143 deaths. By the same time, Nigeria had received a total of 93.9 million doses of the COVID-19 vaccine, enough to vaccinate 25% of the populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Eguavoen, Amenze, Larson, Heidi J, Chinye-Nwoko, Fejiro, Ojeniyi, Toluwanimi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365642/
https://www.ncbi.nlm.nih.gov/pubmed/37492424
http://dx.doi.org/10.4081/jphia.2023.2290
_version_ 1785077037336100864
author Eguavoen, Amenze
Larson, Heidi J
Chinye-Nwoko, Fejiro
Ojeniyi, Toluwanimi
author_facet Eguavoen, Amenze
Larson, Heidi J
Chinye-Nwoko, Fejiro
Ojeniyi, Toluwanimi
author_sort Eguavoen, Amenze
collection PubMed
description By May 30, 2022, there were 526,182,662 confirmed COVID- 19 cases and 6,286,057 deaths globally; of which Nigeria had recorded 256,028 confirmed cases and 3143 deaths. By the same time, Nigeria had received a total of 93.9 million doses of the COVID-19 vaccine, enough to vaccinate 25% of the population; however, only 27.4 million people (13.3% of the population) had received at least one dose of the vaccine. This article examines available evidence on COVID-19 vaccine hesitancy in Nigeria and makes recommendations for improving its uptake. Major causes of COVID-19 vaccine hesitancy identified in Nigeria were concerns around vaccine efficacy and safety, disbelief in the existence and severity of the disease, and distrust of the government. To reduce COVID-19 vaccine hesitancy and improve vaccine coverage in Nigeria, mapping vaccine acceptance and hesitancy across geographies and demographics is needed, as well as increased stakeholder communication, and effective community engagement.
format Online
Article
Text
id pubmed-10365642
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-103656422023-07-25 Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria Eguavoen, Amenze Larson, Heidi J Chinye-Nwoko, Fejiro Ojeniyi, Toluwanimi J Public Health Afr Article By May 30, 2022, there were 526,182,662 confirmed COVID- 19 cases and 6,286,057 deaths globally; of which Nigeria had recorded 256,028 confirmed cases and 3143 deaths. By the same time, Nigeria had received a total of 93.9 million doses of the COVID-19 vaccine, enough to vaccinate 25% of the population; however, only 27.4 million people (13.3% of the population) had received at least one dose of the vaccine. This article examines available evidence on COVID-19 vaccine hesitancy in Nigeria and makes recommendations for improving its uptake. Major causes of COVID-19 vaccine hesitancy identified in Nigeria were concerns around vaccine efficacy and safety, disbelief in the existence and severity of the disease, and distrust of the government. To reduce COVID-19 vaccine hesitancy and improve vaccine coverage in Nigeria, mapping vaccine acceptance and hesitancy across geographies and demographics is needed, as well as increased stakeholder communication, and effective community engagement. PAGEPress Publications, Pavia, Italy 2023-05-04 /pmc/articles/PMC10365642/ /pubmed/37492424 http://dx.doi.org/10.4081/jphia.2023.2290 Text en ©Copyright: the Author(s), https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Eguavoen, Amenze
Larson, Heidi J
Chinye-Nwoko, Fejiro
Ojeniyi, Toluwanimi
Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria
title Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria
title_full Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria
title_fullStr Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria
title_full_unstemmed Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria
title_short Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria
title_sort reducing covid-19 vaccine hesitancy and improving vaccine uptake in nigeria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365642/
https://www.ncbi.nlm.nih.gov/pubmed/37492424
http://dx.doi.org/10.4081/jphia.2023.2290
work_keys_str_mv AT eguavoenamenze reducingcovid19vaccinehesitancyandimprovingvaccineuptakeinnigeria
AT larsonheidij reducingcovid19vaccinehesitancyandimprovingvaccineuptakeinnigeria
AT chinyenwokofejiro reducingcovid19vaccinehesitancyandimprovingvaccineuptakeinnigeria
AT ojeniyitoluwanimi reducingcovid19vaccinehesitancyandimprovingvaccineuptakeinnigeria